• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭患者的生存分析:死亡率建模中时变回归效应的影响

Survival analysis of patients with heart failure: implications of time-varying regression effects in modeling mortality.

作者信息

Giolo Suely Ruiz, Krieger José Eduardo, Mansur Alfredo José, Pereira Alexandre Costa

机构信息

Laboratory of Genetics and Molecular Cardiology, Heart Institute, University of Sao Paulo, Sao Paulo, Sao Paulo, Brazil.

出版信息

PLoS One. 2012;7(6):e37392. doi: 10.1371/journal.pone.0037392. Epub 2012 Jun 8.

DOI:10.1371/journal.pone.0037392
PMID:22715367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3371034/
Abstract

BACKGROUND

Several models have been designed to predict survival of patients with heart failure. These, while available and widely used for both stratifying and deciding upon different treatment options on the individual level, have several limitations. Specifically, some clinical variables that may influence prognosis may have an influence that change over time. Statistical models that include such characteristic may help in evaluating prognosis. The aim of the present study was to analyze and quantify the impact of modeling heart failure survival allowing for covariates with time-varying effects known to be independent predictors of overall mortality in this clinical setting.

METHODOLOGY

Survival data from an inception cohort of five hundred patients diagnosed with heart failure functional class III and IV between 2002 and 2004 and followed-up to 2006 were analyzed by using the proportional hazards Cox model and variations of the Cox's model and also of the Aalen's additive model.

PRINCIPAL FINDINGS

One-hundred and eighty eight (188) patients died during follow-up. For patients under study, age, serum sodium, hemoglobin, serum creatinine, and left ventricular ejection fraction were significantly associated with mortality. Evidence of time-varying effect was suggested for the last three. Both high hemoglobin and high LV ejection fraction were associated with a reduced risk of dying with a stronger initial effect. High creatinine, associated with an increased risk of dying, also presented an initial stronger effect. The impact of age and sodium were constant over time.

CONCLUSIONS

The current study points to the importance of evaluating covariates with time-varying effects in heart failure models. The analysis performed suggests that variations of Cox and Aalen models constitute a valuable tool for identifying these variables. The implementation of covariates with time-varying effects into heart failure prognostication models may reduce bias and increase the specificity of such models.

摘要

背景

已经设计了几种模型来预测心力衰竭患者的生存率。这些模型虽然可用且广泛用于个体层面的分层和决定不同的治疗方案,但存在一些局限性。具体而言,一些可能影响预后的临床变量的影响可能会随时间变化。包含此类特征的统计模型可能有助于评估预后。本研究的目的是分析和量化在考虑已知为该临床环境中总体死亡率独立预测因素的具有时间变化效应的协变量的情况下,对心力衰竭生存率进行建模的影响。

方法

使用比例风险Cox模型以及Cox模型和Aalen加法模型的变体,对2002年至2004年期间诊断为心力衰竭功能分级III级和IV级并随访至2006年的500例患者的起始队列的生存数据进行分析。

主要发现

188例患者在随访期间死亡。对于研究中的患者,年龄、血清钠、血红蛋白、血清肌酐和左心室射血分数与死亡率显著相关。后三者显示出时间变化效应的证据。高血红蛋白和高左心室射血分数均与死亡风险降低相关,且初始效应更强。高肌酐与死亡风险增加相关,也呈现出更强的初始效应。年龄和钠的影响随时间恒定。

结论

当前研究指出了在心力衰竭模型中评估具有时间变化效应的协变量的重要性。所进行的分析表明,Cox模型和Aalen模型的变体是识别这些变量的有价值工具。将具有时间变化效应的协变量纳入心力衰竭预后模型可能会减少偏差并提高此类模型的特异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc6/3371034/021d2d3f48ff/pone.0037392.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc6/3371034/ce631f1d8f1e/pone.0037392.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc6/3371034/42f3355a5658/pone.0037392.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc6/3371034/c2250c75795c/pone.0037392.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc6/3371034/dedad7107d75/pone.0037392.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc6/3371034/d81db4184bc0/pone.0037392.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc6/3371034/021d2d3f48ff/pone.0037392.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc6/3371034/ce631f1d8f1e/pone.0037392.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc6/3371034/42f3355a5658/pone.0037392.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc6/3371034/c2250c75795c/pone.0037392.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc6/3371034/dedad7107d75/pone.0037392.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc6/3371034/d81db4184bc0/pone.0037392.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc6/3371034/021d2d3f48ff/pone.0037392.g006.jpg

相似文献

1
Survival analysis of patients with heart failure: implications of time-varying regression effects in modeling mortality.心力衰竭患者的生存分析:死亡率建模中时变回归效应的影响
PLoS One. 2012;7(6):e37392. doi: 10.1371/journal.pone.0037392. Epub 2012 Jun 8.
2
Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure.保留的右心室射血分数可预测晚期心力衰竭患者的运动能力和生存率。
J Am Coll Cardiol. 1995 Apr;25(5):1143-53. doi: 10.1016/0735-1097(94)00511-n.
3
Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction.心脏磁共振肺通过时间对射血分数降低的晚期心力衰竭患者死亡率和心力衰竭住院的预后价值。
Circ Cardiovasc Imaging. 2021 Jan;14(1):e011680. doi: 10.1161/CIRCIMAGING.120.011680. Epub 2021 Jan 13.
4
Impact of change in serum sodium concentration on mortality in patients hospitalized with heart failure and hyponatremia.血清钠浓度变化对心力衰竭合并低钠血症患者住院死亡率的影响。
Circ Heart Fail. 2011 Sep;4(5):637-43. doi: 10.1161/CIRCHEARTFAILURE.111.961011. Epub 2011 Jun 14.
5
Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure.预测轻至中度慢性心力衰竭患者因进行性心力衰竭导致的死亡
J Am Coll Cardiol. 2002 Nov 20;40(10):1801-8. doi: 10.1016/s0735-1097(02)02490-7.
6
Different prognostic impact of the tissue Doppler-derived E/e' ratio on mortality in Chagas cardiomyopathy patients with heart failure.组织多普勒衍生的 E/e' 比值对心力衰竭的恰加斯心肌病患者死亡率的不同预后影响。
J Heart Lung Transplant. 2012 Jun;31(6):634-41. doi: 10.1016/j.healun.2012.01.865. Epub 2012 Feb 1.
7
Cardiopulmonary exercise parameters in relation to all-cause mortality in patients with chronic heart failure.慢性心力衰竭患者的心肺运动参数与全因死亡率的关系
Int J Cardiol. 2000 Feb 15;72(3):255-63. doi: 10.1016/s0167-5273(99)00195-3.
8
Comparison of Aalen's additive and Cox proportional hazards models for breast cancer survival: analysis of population- based data from British Columbia, Canada.阿alen加法模型与Cox比例风险模型对乳腺癌生存率的比较:基于加拿大不列颠哥伦比亚省人群数据的分析
Asian Pac J Cancer Prev. 2011;12(11):3113-6.
9
[The prognostic value of serum albumin for in-hospital mortality in patients with heart failure basing on propensity score matching].基于倾向评分匹配探讨血清白蛋白对心力衰竭患者院内死亡率的预后价值
Zhonghua Nei Ke Za Zhi. 2015 Nov;54(11):959-64.
10
Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.射血分数>35%的心力衰竭患者死亡率的风险分层。
Am J Cardiol. 2009 Apr 1;103(7):1003-10. doi: 10.1016/j.amjcard.2008.11.061.

引用本文的文献

1
Comparisons of cox semi-parametric and parametric shared frailty models: application for under-five children survival in sub-Saharan Africa.Cox半参数和参数共享脆弱模型的比较:在撒哈拉以南非洲五岁以下儿童生存中的应用。
BMC Public Health. 2025 Aug 22;25(1):2884. doi: 10.1186/s12889-025-24186-x.
2
Assessing survival time of outpatients with cervical cancer: at the university of Gondar referral hospital using the Bayesian approach.评估宫颈癌门诊患者的生存时间:在贡德尔大学转诊医院使用贝叶斯方法。
BMC Womens Health. 2023 Feb 10;23(1):59. doi: 10.1186/s12905-023-02202-9.
3
Survival analysis 101: an easy start guide to analysing time-to-event data.

本文引用的文献

1
National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008.1998-2008 年,医疗保险受益人心力衰竭住院率和死亡率的国家和地区趋势。
JAMA. 2011 Oct 19;306(15):1669-78. doi: 10.1001/jama.2011.1474.
2
Advanced heart failure treated with continuous-flow left ventricular assist device.采用连续血流左心室辅助装置治疗晚期心力衰竭。
N Engl J Med. 2009 Dec 3;361(23):2241-51. doi: 10.1056/NEJMoa0909938. Epub 2009 Nov 17.
3
Are scores useful in advanced heart failure?评分在晚期心力衰竭中有用吗?
生存分析 101:分析事件时间数据的简易入门指南。
Eur J Cardiovasc Nurs. 2023 Apr 12;22(3):332-337. doi: 10.1093/eurjcn/zvad023.
4
Survival time to complications of congestive heart failure patients at Felege Hiwot comprehensive specialized referral hospital, Bahir Dar, Ethiopia.埃塞俄比亚巴赫达尔费莱格·希沃特综合专科医院充血性心力衰竭并发症患者的生存时间。
PLoS One. 2022 Oct 20;17(10):e0276440. doi: 10.1371/journal.pone.0276440. eCollection 2022.
5
Prediction of cardiac events using fully automated GLS and BNP titers in patients with known or suspected heart failure.利用已知或疑似心力衰竭患者的全自动 GLS 和 BNP 滴度预测心脏事件。
PLoS One. 2020 Jun 15;15(6):e0234294. doi: 10.1371/journal.pone.0234294. eCollection 2020.
6
Modeling Long-Term Graft Survival With Time-Varying Covariate Effects: An Application to a Single Kidney Transplant Centre in Johannesburg, South Africa.使用时变协变量效应建模长期移植肾存活:南非约翰内斯堡一家单中心肾移植的应用
Front Public Health. 2019 Jul 25;7:201. doi: 10.3389/fpubh.2019.00201. eCollection 2019.
7
Comparing of Cox model and parametric models in analysis of effective factors on event time of neuropathy in patients with type 2 diabetes.2型糖尿病患者神经病变事件时间影响因素分析中Cox模型与参数模型的比较
J Res Med Sci. 2017 Oct 31;22:115. doi: 10.4103/jrms.JRMS_6_17. eCollection 2017.
8
Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension.查尔森合并症纵向变化对新诊断高血压患者预后生存模型性能的影响。
BMC Health Serv Res. 2016 Nov 22;16(1):671. doi: 10.1186/s12913-016-1910-8.
9
Quantification of Treatment Effect Modification on Both an Additive and Multiplicative Scale.在相加和相乘尺度上对治疗效果修饰进行量化。
PLoS One. 2016 Apr 5;11(4):e0153010. doi: 10.1371/journal.pone.0153010. eCollection 2016.
10
Mitochondrial and genomic ancestry are associated with etiology of heart failure in Brazilian patients.线粒体和基因组血统与巴西患者心力衰竭的病因相关。
J Hum Hypertens. 2016 Feb;30(2):120-3. doi: 10.1038/jhh.2015.39. Epub 2015 May 7.
Expert Rev Cardiovasc Ther. 2009 Aug;7(8):985-97. doi: 10.1586/erc.09.68.
4
Flexible survival regression modelling.灵活的生存回归建模。
Stat Methods Med Res. 2010 Feb;19(1):5-28. doi: 10.1177/0962280209105022. Epub 2009 Jul 16.
5
Prognostic indicators: useful for clinical care?
J Am Coll Cardiol. 2009 Jan 27;53(4):343-4. doi: 10.1016/j.jacc.2008.09.044.
6
Utility of the Seattle Heart Failure Model in patients with advanced heart failure.西雅图心力衰竭模型在晚期心力衰竭患者中的应用价值。
J Am Coll Cardiol. 2009 Jan 27;53(4):334-42. doi: 10.1016/j.jacc.2008.10.023.
7
Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people.1986年至2003年间心力衰竭首次住院的长期趋势及后续生存率:一项对510万人的人群研究。
Circulation. 2009 Feb 3;119(4):515-23. doi: 10.1161/CIRCULATIONAHA.108.812172. Epub 2009 Jan 19.
8
Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).因心力衰竭住院患者院内死亡的预测因素:来自心力衰竭住院患者启动挽救生命治疗组织项目(OPTIMIZE-HF)的见解
J Am Coll Cardiol. 2008 Jul 29;52(5):347-56. doi: 10.1016/j.jacc.2008.04.028.
9
Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.左心室辅助装置植入作为终末期治疗在 REMATCH 时代后的结局:对患者选择的启示。
Circulation. 2007 Jul 31;116(5):497-505. doi: 10.1161/CIRCULATIONAHA.107.691972. Epub 2007 Jul 16.
10
The Seattle Heart Failure Model: prediction of survival in heart failure.西雅图心力衰竭模型:心力衰竭患者生存率的预测
Circulation. 2006 Mar 21;113(11):1424-33. doi: 10.1161/CIRCULATIONAHA.105.584102. Epub 2006 Mar 13.